Merck & Co Inc (NYSE:MRK)
| 86.78 Delayed Data As of 4:00pm ET |  +0.94 / +1.10%Today’s Change | 71.50 Today|||52-Week Range 95.72 | +13.23% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 85.84 |
| Today’s open | 86.94 |
| Day’s range | 86.21 - 87.24 |
| Volume | 6,839,999 |
| Average volume (3 months) | 9,739,114 |
| Market cap | $219.8B |
Data as of 4:00pm ET, 09/28/2022
Growth & Valuation
| Earnings growth (last year) | +84.65% |
| Earnings growth (this year) | +22.76% |
| Earnings growth (next 5 years) | +11.30% |
| Revenue growth (last year) | +1.86% |
| P/E ratio | 13.3 |
| Price/Sales | 3.98 |
| Price/Book | 5.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.31 | +0.70% |
| ABBVAbbVie | +2.85 | +2.01% |
| NVONovo Nordisk | +3.44 | +3.59% |
| AZNAstraZeneca | +1.45 | +2.72% |
Data as of 4:00pm ET, 09/28/2022
Financials
| Next reporting date | October 27, 2022 |
| EPS forecast (this quarter) | $1.76 |
| Annual revenue (last year) | $48.9B |
| Annual profit (last year) | $13.0B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
